Barr Laboratory BRL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: E. Graphs who wrote (128)	10/21/1998 10:00:00 AM
From: E. Graphs	Read Replies (1) of 207

Barr Granted Injunction Preventing Restrictions on Generics; biz.yahoo.com >>Travis County District Judge Jeanne Meurer has blocked implementation of a Board of Pharmacy rule that would have limited generic substitution in Texas. The decision is a blow to the efforts of DuPont Pharmaceuticals to preserve its Texas monopoly on Coumadin(r) anticoagulant. >>Since January of 1997, DuPont Merck has been engaged in a state-by-state effort to block competition for their Coumadin product, which has been off patent since 1962. DuPont has increased the price of its Coumadin product more than 400% in the past decade.<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next